Danish Pharmacovigilance Update, March 2017

In this issue

• The European Pharmacovigilance Risk Assessment Committee, PRAC, recommends regulatory measures – including suspension of the marketing authorisation for some gadolinium-containing contrast agents
• The DKMA seeks more knowledge about the use of quetiapine in children and adolescents
• Childhood vaccinations and reported suspected adverse reactions in Q4 of 2016
• EU's list of recommendations on safety signals
• Most recent Direct Healthcare Professional Communications (DHPCs)

Link

Danish Pharmocovigilance Update, March 2017